Saisam Generico Medicines Llp - Company Profile

It is a home appliances limited liability partnership based in Nerul Navi Mumbai, Maharashtra, India, established in 2021.
2021 Nerul Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Saisam Generico Medicines Llp

Saisam Generico Medicines Llp, a active limited liability partnership, was established on 16 March 2021 in Nerul Navi Mumbai, Maharashtra, India. Engaging in repair of personal and household goods within the home appliances sector, it holds LLPIN: AAW-3492. Registered under ROC Roc Mumbai Ii. It has total obligation of contribution of ₹10.00 K .

Its leadership includes Priti Sambhaji Garad (Designated Partner), Rajitha Ashok Kattekola (Designated Partner), Balkrishna Vasant Joshi (Designated Partner). It is based at Plot No. 3, Sector 16, Nerul (W), Nerul Navi Mumbai, Maharashtra, 400706.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAW-3492

  • Incorporation Date

    16 March 2021

  • Total Obligation of Contribution

    ₹10.00 K

  • ROC Code

    Roc Mumbai Ii

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 10.00 K
  • Company Age 5 Year, 3 Months
Company report

Saisam Generico Medicines Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Saisam Generico Medicines Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Saisam Generico Medicines Llp?
Current Designated Partners
Name Designation Appointment Date Status
Priti Sambhaji Garad Designated Partner 16 Mar 2021 Current
Rajitha Ashok Kattekola Designated Partner 16 Mar 2021 Current
Balkrishna Vasant Joshi Designated Partner 16 Mar 2021 Current
Rajmohammad Sikandar Inamdar Designated Partner 16 Mar 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Saisam Generico Medicines Llp.

Enhance accessibility to Saisam Generico Medicines Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Saisam Generico Medicines Llp revenue growth over time
Saisam Generico Medicines Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Saisam Generico Medicines Llp?

Unlock access to Saisam Generico Medicines Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Saisam Generico Medicines Llp?

Unlock and access historical data on people associated with Saisam Generico Medicines Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Saisam Generico Medicines Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saisam Generico Medicines Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Saisam Generico Medicines Llp
Recent Activity within the Organization
  • Director Appointment

    Priti Sambhaji Garad was appointed as a Designated Partner was appointed as a Designated Partner on 16 Mar 2021 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Rajitha Ashok Kattekola was appointed as a Designated Partner was appointed as a Designated Partner on 16 Mar 2021 & has been associated with this company since 5 years 3 months . was documented.

  • Director Appointment

    Progress on Balkrishna Vasant Joshi was appointed as a Designated Partner was appointed as a Designated Partner on 16 Mar 2021 & has been associated with this company since 5 years 3 months . was documented.

  • Director Appointment

    Progress on Rajmohammad Sikandar Inamdar was appointed as a Designated Partner was appointed as a Designated Partner on 16 Mar 2021 & has been associated with this company since 5 years 3 months . was documented.

  • LLP Incorporation

    Progress on Saisam Generico Medicines Llp was registered on 16 Mar 2021 with Roc Mumbai Ii & aged 5 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Saisam Generico Medicines Llp?

The LLPIN of Saisam Generico Medicines Llp is AAW-3492.

Where is Saisam Generico Medicines Llp headquartered?

Saisam Generico Medicines Llp is headquartered at Plot No. 3, Sector 16, Nerul (W), Nerul Navi Mumbai, Maharashtra, 400706.

When was Saisam Generico Medicines Llp incorporated?

Saisam Generico Medicines Llp was incorporated on 16 March 2021.

Who are the current directors of Saisam Generico Medicines Llp?

The current directors of Saisam Generico Medicines Llp are

What is the primary industry of Saisam Generico Medicines Llp?

The primary industry of Saisam Generico Medicines Llp is Home Appliances.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available